Defining a comprehensive verotype using electronic health records for personalized medicine

被引:50
作者
Boland, Mary Regina [1 ]
Hripcsak, George [1 ]
Shen, Yufeng [1 ,2 ]
Chung, Wendy K. [3 ,4 ,5 ]
Weng, Chunhua [1 ,5 ]
机构
[1] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA
[2] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA
[3] Columbia Univ, Dept Pediat, New York, NY 10032 USA
[4] Columbia Univ, Dept Med, New York, NY 10032 USA
[5] Columbia Univ, Irving Inst Clin & Translat Res, New York, NY 10032 USA
关键词
AMYOTROPHIC-LATERAL-SCLEROSIS; GENE-EXPRESSION SIGNATURES; PARKINSONS-DISEASE; NETWORK MEDICINE; BREAST-CANCER; EYE COLOR; SMOKING STATUS; SUBTYPES; ENDOPHENOTYPES; IDENTIFICATION;
D O I
10.1136/amiajnl-2013-001932
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
The burgeoning adoption of electronic health records (EHR) introduces a golden opportunity for studying individual manifestations of myriad diseases, which is called 'EHR phenotyping'. In this paper, we break down this concept by: relating it to phenotype definitions from Johannsen; comparing it to cohort identification and disease subtyping; introducing a new concept called 'verotype' (Latin: vere = true, actually) to represent the 'true' population of similar patients for treatment purposes through the integration of genotype, phenotype, and disease subtype (eg, specific glucose value pattern in patients with diabetes) information; analyzing the value of the 'verotype' concept for personalized medicine; and outlining the potential for using network-based approaches to reverse engineer clinical disease subtypes.
引用
收藏
页码:E232 / E238
页数:7
相关论文
共 91 条
  • [51] Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities
    Maher, Elizabeth A.
    Brennan, Cameron
    Wen, Patrick Y.
    Durso, Laura
    Ligon, Keith L.
    Richardson, Aaron
    Khatry, Deepak
    Feng, Bin
    Sinha, Raktim
    Louis, David N.
    Quackenbush, John
    Black, Peter McL.
    Chin, Lynda
    DePinho, Ronald A.
    [J]. CANCER RESEARCH, 2006, 66 (23) : 11502 - 11513
  • [52] Parkinson's disease subtypes: lost in translation?
    Marras, Connie
    Lang, Anthony
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (04) : 409 - 415
  • [53] McCormick RK, 2007, ALTERN MED REV, V12, P113
  • [54] Mendel G., 1822, Versuche uber Pflanzen-Hybriden, DOI [DOI 10.5962/BHL.TITLE.61004, 10.5962/bhl.title.61004]
  • [55] Mendel G., 1996, EXPT PLANT HYBRIDIZA
  • [56] Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis
    Murphy, Jennifer
    Henry, Roland
    Lomen-Hoerth, Catherine
    [J]. ARCHIVES OF NEUROLOGY, 2007, 64 (03) : 330 - 334
  • [57] National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL
  • [58] Development and Validation of an Electronic Health Record-Based Chronic Kidney Disease Registry
    Navaneethan, Sankar D.
    Jolly, Stacey E.
    Schold, Jesse D.
    Arrigain, Susana
    Saupe, Well
    Sharp, John
    Lyons, Jennifer
    Simon, James F.
    Schreiber, Martin J., Jr.
    Jain, Anil
    Nally, Joseph V., Jr.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (01): : 40 - 49
  • [59] Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction
    Nevins, JR
    Huang, ES
    Dressman, H
    Pittman, J
    Huang, AT
    West, M
    [J]. HUMAN MOLECULAR GENETICS, 2003, 12 : R153 - R157
  • [60] Genetic determinants of cancer metastasis
    Nguyen, Don X.
    Massague, Joan
    [J]. NATURE REVIEWS GENETICS, 2007, 8 (05) : 341 - 352